To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support a multidisciplinary approach to understanding the pathology of the long term symptoms of covid-19.
15 September 2020
The National Institute for Health Research and UK Research and Innovation have invested £8.4million in the Post-HOSPitalisation COVID-19 study (PHOSP-COVID), led by Christopher Brightling at the University of Leicester. The study is multi-disciplinary and is one of the world’s largest comprehensive research studies into the long-term health impacts of COVID-19 on hospitalised patients.
This study will create a research platform embedded within clinical care to understand the long-term outcomes for survivors following hospitalisation with COVID-19. Expert groups from across the United Kingdom will use standardised assessments of patients, including advanced imaging, recording of information and collection of samples, and will also cover the study of novel interventions in the rehabilitation pathway, including mental health interventions.